Evidence map›Paper›PMID 28376131›Full record

ArticlePloS one2017

Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population.

Nicholas T Au, Morayma Reyes, Bert B Boyer, Scarlett E Hopkins, Jynene Black, Diane O'Brien, Alison E Fohner, Joe Yracheta, Timothy Thornton, Melissa A Austin and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational Analyses of Ex Vivo Native American Platelet Responses.International journal of molecular sciences · 2024
    Observational
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Nicholas T AuDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
Morayma ReyesDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.
Bert B BoyerCenter for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America.
Scarlett E HopkinsCenter for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America.
Jynene BlackCenter for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America.
Diane O'BrienCenter for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America.
Alison E FohnerPublic Health Genetics, University of Washington, Seattle, Washington, United States of America.
Joe YrachetaDepartment of Pharmaceutics, University of Washington, Seattle, Washington, United States of America.
Timothy ThorntonDepartment of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Melissa A AustinDepartment of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Wylie BurkeDepartment of Medical Ethics, University of Washington, Seattle, Washington, United States of America.
Kenneth E ThummelDepartment of Pharmaceutics, University of Washington, Seattle, Washington, United States of America.
Allan E RettieDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.ORCID http://orcid.org/0000-0001-9894-8753
University of Washington · USUniversity of Alaska Fairbanks · US

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
Pharmacogenetics in Rural and Underserved PopulationsU01GM092676 · NIGMS · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., THUMMEL, KENNETH E. · 2010 to 2014
$9.9M
Statistical Methods for X-Chromosome Genetic DataP01GM099568 · NIGMS · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2012 to 2016
$7.3M
Pilot Project ProgramP30GM103325 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BERSAMIN, ANDREA · 2012 to 2016
$5.3M
Genetics of Obesity in Yup'ik EskimosR01DK074842 · NIDDK · UNIVERSITY OF ALASKA FAIRBANKS · PI BOYER, BERT BRANDON · 2007 to 2011
$2.8M
Institute for Translational Health Science (TL1)TL1RR025016 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$2.7M
New Vistas in Vitamin K MetabolismR01GM109743 · NIGMS · UNIVERSITY OF WASHINGTON · PI RETTIE, ALLAN EDWARD · 2013 to 2016
$1.1M
NCRR NIH HHS TL1 RR025016NIDDK NIH HHS R01 DK074842NIEHS NIH HHS P30 ES007033NIGMS NIH HHS P01 GM099568NIGMS NIH HHS P30 GM103325NIGMS NIH HHS R01 GM109743NIGMS NIH HHS U01 GM092676
6 · The paper itself

Abstract

Fish and marine animals are important components of the subsistence diet of Alaska Native people, resulting in a high ω3 PUFA intake. The historical record for circumpolar populations highlights a tendency for facile bleeding, possibly related to ω3 PUFA effects on platelet activation and/or vitamin K-dependent clotting factors. To evaluate these two scenarios in Yup'ik people of southwestern Alaska, we examined the association between dietary ω3 PUFA intake and activities of clotting factor II, V, fibrinogen, PT, INR, PTT, and sP-selectin in 733 study participants, using the nitrogen isotope ratio of red blood cells as a biomarker of ω3 PUFA consumption. sP-selectin alone correlated strongly and inversely with ω3 PUFA consumption. Approximately 36% of study participants exhibited PIVKA-II values above the threshold of 2 ng/ml, indicative of low vitamin K status. To assess genetic influences on vitamin K status, study participants were genotyped for common vitamin K cycle polymorphisms in VKORC1, GGCX and CYP4F2. Only CYP4F2*3 associated significantly with vitamin K status, for both acute (plasma vitamin K) and long-term (PIVKA-II) measures. These findings suggest: (i) a primary association of ω3 PUFAs on platelet activation, as opposed to vitamin K-dependent clotting factor activity, (ii) that reduced CYP4F2 enzyme activity associates with vitamin K status. We conclude that high ω3 PUFA intake promotes an anti-platelet effect and speculate that the high frequency of the CYP4F2*3 allele in Yup'ik people (~45%) evolved in response to a need to conserve body stores of vitamin K due to environmental limitations on its availability.

Indexed as

DietAdolescentAdultAlaskaAlaska NativesAnimalsBiomarkersBlood CoagulationBlood Coagulation FactorsCarbon-Carbon LigasesCross-Sectional StudiesCytochrome P450 Family 4Fatty Acids, Omega-3FemaleGenotypeHemostasisacarboxyprothrombinBiomarkersBlood Coagulation FactorsCarbon-Carbon LigasesCYP4F2 protein, humanCytochrome P450 Family 4Fatty Acids, Omega-3glutamyl carboxylaseProtein PrecursorsProthrombinP-SelectinVitamin KVitamin K Epoxide ReductasesVKORC1 protein, human

Identifiers

PMID28376131
PMCPMC5380313
OpenAlexW2604209266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.